Surface Oncology, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Surface Oncology, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q4 2022.
  • Surface Oncology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 31, 2022 was $5.63M, a 4.01% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $5.63M +$217K +4.01% Dec 31, 2022 8-K 2023-07-03
Q4 2021 $5.41M +$28K +0.52% Dec 31, 2021 8-K 2023-07-03
Q4 2020 $5.39M -$144K -2.6% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $5.53M +$607K +12.3% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $5.53M +$607K +12.3% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $5.53M +$607K +12.3% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $5.53M Dec 31, 2019 10-K 2021-03-09
Q3 2019 $4.92M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.92M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $4.92M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.